Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Ironwood Pharma Promotes Tammi Gaskins to Succeed CEO Tom McCourt
Ironwood Pharmaceuticals' Chief Commercial Officer Tammi Gaskins has been appointed to succeed Chief Executive Tom McCourt when he retires after 17 years at the biotechnology company. Boston-based Ironwood said Gaskins will step into the role…
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
Biopharma stocks like AbbVie and Eli Lilly are trading at or near all-time highs, in the latest signal that investors are seeking out the steady gains that come with large, diversified drugmakers. These companies are doing what they do best…
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
Should an investor saving for retirement put their next dollar of income capital into Amgen (NASDAQ:AMGN | AMGN Price Prediction) or Merck (NYSE:MRK)? The two yields are near identical. Amgen's annualized forward dividend of $10.08 on a $437.04…
Troy Jackson got $15k from big oil, pharma lobbyists. He's giving it to charity.
Read all of our coverage of Maine's 2026 election or stay up to date with the latest developments through the Maine Political Report in your inbox or text messages from politics editor Kirby Wilson. Troy Jackson is donating about $15,000 in…
Ascentage Pharma Group International - Unsponsored ADR (AAPG) - What Are Researchers Thinking About This Stock?
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) have earned a consensus recommendation of 'Buy' from the fourteen ratings firms that are currently covering the company, MarketBeat reports. Twelve…
Royalty Pharma PLC $RPRX Shares Purchased by Triasima Portfolio Management inc.
Triasima Portfolio Management inc. raised its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 23.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned…
Smoke and Mirrors: The Right's Latest Attacks Against Trans People
Bluesky In the final weeks of the 2024 election, the refrain “ Kamala is for They/Them, Trump is for You ” blared from TVs in the battleground states during NFL and college-football games. Seeking to capitalize on voters' frustrations…
Ascendis Gets EMA Recommendation for Approval for Achondroplasia Treatment in Children
A committee from the European Medicines Agency recommending granting marketing authorization for Ascendis Pharma's treatment for achondroplasia in children. The EMA's Committee for Medicinal Products for Human Use said Friday that Ascendis's…
Editorial. Fatally expensive
Of late, courts have taken a serious view of the astronomical prices of cancer drugs. Responding to the concerns of the Supreme Court — and before that, Kerala High Court — the Centre has said that it will cap the MRP of…
Berlin and Paris open 'Made in Europe' door to Switzerland
Switzerland would be treated on an equal footing with the countries of the European Economic Area and the United Kingdom. This is according to a Franco-German position paper published on Thursday, a copy of which has been seen by the Keystone-SDA…
Korea's 1st homegrown obesity drug likely to intensify price competition
Korea's first homegrown obesity drug could shake up a market dominated by Mounjaro and Wegovy, an industry official said, as more Koreans travel to Japan to obtain cheaper Mounjaro and bring it home illegally, driven by the high cost of obesity…
NGL Energy Partners: Booming Water Business, But Common Units Look Expensive (NYSE:NGL)
NGL Energy Partners is rated 'Sell' due to high leverage, preferred obligations, and limited upside at current valuations. Water Solutions drives strong EBITDA margins, but over half of revenue growth is from less predictable recovered crude oil…
Erasca, Inc: The Discount RevMed? (NASDAQ:ERAS)
Erasca, Inc. is positioned as a key contender in the transformative KRAS inhibitor market, trailing Revolution Medicines but showing promising early data. ERAS-0015 demonstrates strong preliminary response rates in KRAS-mutated pancreatic and lung…
Xtalks Named Media Partner for the 2026 CTO Clinical Trials Conference
The 2026 conference will explore how Canada can strengthen its position in global clinical research, with discussions on improving trial efficiency, integrating research into patient care and expanding access to clinical trials. 'CTO's Clinical…
Stock Market Highlights, Oct 16: Sensex gains 413 pts, Nifty ends at 23,146 led by IT stocks
Sensex Today, Nifty 50 | Stock Market Highlights: Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 16th October 2026. Sensex settled 413.66 pts or 0.56% higher at 74,729.27 on Friday, Nifty…
Receive a Daily briefing on Pharma Industry News
Get Started